NLRP3 and metabolic disease: These findings indicate that such a physical intervention constitutes an effective strategy for mitigating low-grade chronic inflammation commonly associated with metabolic diseases such as obesity and type 2 diabetes through the downregulation of the NLRP3 inflammasome.